Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation ; volume:16 ; number:1 ; day:13 ; month:7 ; year:2016 ; pages:1-9 ; date:12.2016
BMC cancer ; 16, Heft 1 (13.7.2016), 1-9, 12.2016

Creator: Han, Kelong

Contributor: Claret, Laurent
Sandler, Alan
Das, Asha
Jin, Jin
Bruno, Rene
SpringerLink (Online service)

DOI: 10.1186/s12885-016-2455-2

URN: urn:nbn:de:101:1-2018071223351194496139

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Han, Kelong
Claret, Laurent
Sandler, Alan
Das, Asha
Jin, Jin
Bruno, Rene
SpringerLink (Online service)

Other Objects (12)

Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a prognostic index

First-line management of metastatic non-small cell lung cancer: An Indian perspective

Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

External validation of the Tyrolean hip arthroplasty registry

Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy

Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a prognostic index

First-line management of metastatic non-small cell lung cancer: An Indian perspective

Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

External validation of the Tyrolean hip arthroplasty registry

Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy

Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a prognostic index

First-line management of metastatic non-small cell lung cancer: An Indian perspective

Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

External validation of the Tyrolean hip arthroplasty registry

Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a prognostic index

First-line management of metastatic non-small cell lung cancer: An Indian perspective

Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

External validation of the Tyrolean hip arthroplasty registry

Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy

Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a prognostic index

First-line management of metastatic non-small cell lung cancer: An Indian perspective

Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

External validation of the Tyrolean hip arthroplasty registry

Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy

Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a prognostic index

First-line management of metastatic non-small cell lung cancer: An Indian perspective

Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

External validation of the Tyrolean hip arthroplasty registry

Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy

Related objects

Reset password